Beatrice Noce
Rome, 00185, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor.
Journal: Journal of medicinal chemistry
Published: March 05, 2025
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.
Journal: Cell death discovery
Published: February 07, 2024
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells.
Journal: Journal of medicinal chemistry
Published: July 13, 2023
Targeting ROS production through inhibition of NADPH oxidases.
Journal: Nature chemical biology
Published: May 03, 2023
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials.
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials.
Journal: Frontiers in pharmacology
Published: December 10, 2022
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages.
Journal: ChemMedChem
Published: September 21, 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells.
Journal: European journal of medicinal chemistry
Published: September 19, 2022
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: March 23, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026